Chinese scientists have successfully cloned the first healthy rhesus monkey, named Retro, using a modified technique based on the original method that produced Dolly the sheep. This breakthrough addresses previous challenges in primate cloning by replacing the cells that form the placenta with those from a normal embryo, significantly improving the success rate of cloning through somatic cell nuclear transfer (SCNT). Despite this advancement, researchers caution that the overall success rate remains low, with only one out of 113 embryos surviving to birth.

Editor’s Note: The successful cloning of primates raises profound ethical questions, particularly regarding the use of clones for research purposes. While cloning can advance scientific knowledge and medical treatments, it also risks reducing sentient beings to mere tools for experimentation, potentially leading to exploitation and suffering. The ethical implications become even more complex when considering human cloning; the prospect of creating genetically identical individuals poses challenges related to identity, autonomy, and the moral status of clones.

Should clones be afforded the same legal rights as their “originals”? Many argue that all sentient beings deserve equal rights regardless of their origin, emphasizing that clones should not be treated as second-class entities. This perspective aligns with broader human rights principles that advocate for dignity and respect for all individuals. We have no business playing god if we cannot even determine the answers to these fundamental questions.

Read Original Article